UK markets open in 1 hour 9 minutes

MEI Pharma, Inc. (0JW9.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
3.2328-0.5387 (-14.28%)
At close: 06:27PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-29.33%
S&P500 52-week change 321.08%
52-week high 37.8585
52-week low 30.0000
50-day moving average 35.6657
200-day moving average 35.9890

Share statistics

Avg vol (3-month) 3400
Avg vol (10-day) 3603
Shares outstanding 571.13M
Implied shares outstanding 6N/A
Float 84.94M
% held by insiders 10.54%
% held by institutions 147.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.05:1
Last split date 317 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 27.31%
Operating margin (ttm)20.67%

Management effectiveness

Return on assets (ttm)8.30%
Return on equity (ttm)36.79%

Income statement

Revenue (ttm)72.65M
Revenue per share (ttm)10.90
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 15.38M
Net income avi to common (ttm)19.84M
Diluted EPS (ttm)-0.5190
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)59.48M
Total cash per share (mrq)8.93
Total debt (mrq)12.03M
Total debt/equity (mrq)20.22%
Current ratio (mrq)8.23
Book value per share (mrq)8.93

Cash flow statement

Operating cash flow (ttm)-52.98M
Levered free cash flow (ttm)433.62k